Home Newsfeeds Atlantic Equities Maintains Underweight on Amgen, Lowers Price Target to $182

Atlantic Equities Maintains Underweight on Amgen, Lowers Price Target to $182

Atlantic Equities analyst Steve Chesney maintains Amgen (NASDAQ:AMGN) with a Underweight and lowers the price target from $190 to $182.

byBenzinga Newsdesk

August 9, 2022

1 minute read

Atlantic Equities analyst Steve Chesney maintains Amgen (NASDAQ:AMGN) with a Underweight and lowers the price target from $190 to $182.

These Analysts Cut Their Forecasts On Abbott After Q3 Results

By Lisa Levin

October 19, 2:28 PM

Abbott Laboratories (NYSE: ABT) reported better-than-expected third-quarter results.

ABT

Carvana Shares Skyrocket 40% After Strong Q2, Options Traders Bet On Continued Rally

By Priya Nigam

July 20, 8:23 AM

Carvana Co. (NYSE: CVNA) shares traded sharply higher on Wednesday after the company reported better-than-expected second-quarter sales and guided positive adjusted EBITDA for the third quarter.

CVNA

Award-Winning Mary’s Medicinals And Dixie Brands Cannabis Coming Soon To Arkansas

By Jelena Martinovic

October 24, 10:46 AM

Cannabis multi-state house of brands BellRock Brands Inc. (OTCEM: DXBRF) (CSE: BRCK.U) has entered into a licensing agreement with Dark Horse Medicinals, LLC to bring the Mary's Medicinals and Dixie Brands to Arkansas.

CSE:BRCK

News

S. Korea’s Yonhap News Agency Reported N. Korea Fired Artillery Shots Sunday, Presumably From Multiple Rocket Launchers

By Charles Gross

July 10, 8:07 AM

https://en.yna.co.kr/view/AEN20220710002952325?input=tw

Atlantic Equities Maintains Underweight on Amgen, Lowers Price Target to $182

Related Posts

These Analysts Cut Their Forecasts On Abbott After Q3 Results

Carvana Shares Skyrocket 40% After Strong Q2, Options Traders Bet On Continued Rally

Award-Winning Mary’s Medicinals And Dixie Brands Cannabis Coming Soon To Arkansas

S. Korea’s Yonhap News Agency Reported N. Korea Fired Artillery Shots Sunday, Presumably From Multiple Rocket Launchers